Nedimesken (Talk | contribs) |
Nedimesken (Talk | contribs) |
||
Line 113: | Line 113: | ||
− | + | ||
<p> | <p> | ||
In order to be able to grow colonies of DH5α with our first, second and third composite parts; we’ve initially ligated the parts to pSB1C3 backbone. composite part 1’s insert to vector ratio was 1:3, composite 2’s was 1:2 and composite 3’s (Bio-E) was 1:1,5. After that, we’ve transformed the ligations to DH5α competent cells and grew the colonies on LB agar plates containing chloramphenicol at a final concentration of 40 µg/ml. After obtaining DH5α colonies, we’ve done colony PCR and considering the results that we obtained, we’ve decided the best outcomes were from the 3rd colony from composite 1, 6th colony from composite 2 and 3rd from composite 3. | In order to be able to grow colonies of DH5α with our first, second and third composite parts; we’ve initially ligated the parts to pSB1C3 backbone. composite part 1’s insert to vector ratio was 1:3, composite 2’s was 1:2 and composite 3’s (Bio-E) was 1:1,5. After that, we’ve transformed the ligations to DH5α competent cells and grew the colonies on LB agar plates containing chloramphenicol at a final concentration of 40 µg/ml. After obtaining DH5α colonies, we’ve done colony PCR and considering the results that we obtained, we’ve decided the best outcomes were from the 3rd colony from composite 1, 6th colony from composite 2 and 3rd from composite 3. | ||
</p> | </p> | ||
− | <div class=" | + | <div class="col-md-4"> |
<img src="https://static.igem.org/mediawiki/2018/c/c4/T--METU_HS_Ankara--res05.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/c/c4/T--METU_HS_Ankara--res05.jpg" /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 5: Plate image showing composite part 1 (FucO) transformed DH5α. The medium was LB with Chl 40. | ||
+ | </i> | ||
</div> | </div> | ||
− | < | + | <div class="col-md-4"> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/1/18/T--METU_HS_Ankara--res06.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/1/18/T--METU_HS_Ankara--res06.jpg" /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 6: Plate image showing composite part 2 (GSH) transformed DH5α. The medium was LB with Chl 40. | ||
+ | </i> | ||
</div> | </div> | ||
− | < | + | <div class="col-md-4"> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<img src="https://static.igem.org/mediawiki/2018/e/e6/T--METU_HS_Ankara--res07.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/e/e6/T--METU_HS_Ankara--res07.jpg" /> | ||
+ | <i class="parts-info"> | ||
+ | Figure 7: Plate image showing composite part 3 (GSH & FucO) transformed DH5α. The medium was LB with Chl 40. | ||
+ | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
<h3>Composite part 1 (FucO) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571003">BBa_K2571003</a>) PCR Confirmation:</h3> | <h3>Composite part 1 (FucO) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571003">BBa_K2571003</a>) PCR Confirmation:</h3> | ||
Line 148: | Line 145: | ||
</p> | </p> | ||
− | <div class=" | + | <div class="col-md-12" style="text-align:center"> |
− | <img src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | + | <img width="700" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> |
+ | <div style="clear:both"></div> | ||
+ | <i class="parts-info"> | ||
+ | Figure 8: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1C3 | ||
+ | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
<h3>Composite part 2 (GSH) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571005">BBa_K2571005</a>) PCR Confirmation:</h3> | <h3>Composite part 2 (GSH) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571005">BBa_K2571005</a>) PCR Confirmation:</h3> | ||
Line 162: | Line 159: | ||
</p> | </p> | ||
− | <div class=" | + | <div class="col-md-12" style="text-align:center"> |
− | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | + | <img width="700" src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> |
+ | <div style="clear:both"></div> | ||
+ | <i class="parts-info"> | ||
+ | Figure 9: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1C3. | ||
+ | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
<h3>Composite part 3: Dual Insertion of FucO and GSH in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571006">BBa_K2571006</a>) PCR Confirmation:</h3> | <h3>Composite part 3: Dual Insertion of FucO and GSH in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571006">BBa_K2571006</a>) PCR Confirmation:</h3> | ||
Line 176: | Line 173: | ||
</p> | </p> | ||
− | <div class=" | + | <div class="col-md-12" style="text-align:center"> |
− | <img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | + | <img width="700" src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> |
+ | <div style="clear:both"></div> | ||
+ | <i class="parts-info"> | ||
+ | Figure 10: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) insertion into pSB1C3. | ||
+ | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
<h3>KO11 Clonings:</h3> | <h3>KO11 Clonings:</h3> |
Revision as of 13:58, 16 October 2018